Research graph
References from Comprehensive pan-cancer analysis unveils the significant prognostic value and potential role in immune microenvironment modulation of TRIB3. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3322/caac.21660
10.3322/caac.21660 · External reference
10.3322/caac.21731
10.3322/caac.21731 · External reference
10.1158/0008-5472.can-07-6611
10.1158/0008-5472.can-07-6611 · External reference
10.1186/s13045-021-01164-5
10.1186/s13045-021-01164-5 · External reference
10.1016/s0140-6736(20)32598-8
10.1016/s0140-6736(20)32598-8 · External reference
10.1038/nature21349
10.1038/nature21349 · External reference
10.1016/j.it.2022.04.010
10.1016/j.it.2022.04.010 · External reference
10.3390/cancers13081822
10.3390/cancers13081822 · External reference
10.1172/jci36849
10.1172/jci36849 · External reference
10.1074/jbc.m703735200
10.1074/jbc.m703735200 · External reference
10.1126/science.1123374
10.1126/science.1123374 · External reference
10.1182/blood-2009-10-246264
10.1182/blood-2009-10-246264 · External reference
10.1074/jbc.m407732200
10.1074/jbc.m407732200 · External reference
10.1126/science.1079817
10.1126/science.1079817 · External reference
10.1194/jlr.m700545-jlr200
10.1194/jlr.m700545-jlr200 · External reference
10.1016/j.cellsig.2008.01.010
10.1016/j.cellsig.2008.01.010 · External reference
10.1038/s41467-020-17385-0
10.1038/s41467-020-17385-0 · External reference
10.1053/j.gastro.2018.10.031
10.1053/j.gastro.2018.10.031 · External reference
10.1016/j.intimp.2022.109581
10.1016/j.intimp.2022.109581 · External reference
10.1042/bst20150124
10.1042/bst20150124 · External reference
10.1038/s41467-019-13700-6
10.1038/s41467-019-13700-6 · External reference
Tribbles pseudokinase 3 (TRIB3) contributes to the progression of hepatocellular carcinoma by activating the mitogen-activated protein kinase pathway
10.21037/atm-21-2820 · 2021 · External reference
Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer
10.1186/s12885-022-09593-2 · 2022 · External reference
TRIB3 facilitates glioblastoma progression via restraining autophagy
10.18632/aging.103969 · 2020 · External reference
Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway
10.1186/s12935-020-01509-z · 2020 · External reference
TRIB3 promotes oral squamous cell carcinoma cell proliferation by activating the AKT signaling pathway
10.3892/etm.2021.9744 · 2021 · External reference
10.3892/or.2016.5017
10.3892/or.2016.5017 · External reference
10.1038/sj.bjc.6605361
10.1038/sj.bjc.6605361 · External reference
TRIB3 promotes the malignant progression of bladder cancer: an integrated analysis of bioinformatics and in vitro experiments
10.3389/fgene.2021.649208 · 2021 · External reference
TRIB3 protein denotes a good prognosis in breast cancer patients and is associated with hypoxia sensitivity
10.1016/j.radonc.2011.05.057 · 2011 · External reference
TRB3 reverses chemotherapy resistance and mediates crosstalk between endoplasmic reticulum stress and AKT signaling pathways in MHCC97H human hepatocellular carcinoma cells
2018 · External reference
10.1038/s41587-020-0546-8
10.1038/s41587-020-0546-8 · External reference
10.1158/2159-8290.cd-12-0095
10.1158/2159-8290.cd-12-0095 · External reference
10.1093/nar/gks1193
10.1093/nar/gks1193 · External reference
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 · External reference
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
2019 · External reference
10.1126/science.aan2507
10.1126/science.aan2507 · External reference
10.1186/s13072-019-0316-3
10.1186/s13072-019-0316-3 · External reference
10.1093/nar/gkx1090
10.1093/nar/gkx1090 · External reference
10.1038/ncomms3612
10.1038/ncomms3612 · External reference
10.1093/annonc/mdy495
10.1093/annonc/mdy495 · External reference
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
10.1186/s12943-018-0864-3 · 2018 · External reference
10.1038/s41571-018-0004-4
10.1038/s41571-018-0004-4 · External reference
10.1016/j.cub.2020.06.081
10.1016/j.cub.2020.06.081 · External reference
Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response
10.1186/s13045-021-01103-4 · 2021 · External reference
Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response
10.1186/bcr2934 · 2011 · External reference
10.3390/cancers13215307
10.3390/cancers13215307 · External reference
10.1073/pnas.1214014110
10.1073/pnas.1214014110 · External reference
10.3390/cancers11020127
10.3390/cancers11020127 · External reference
10.1038/s41467-022-34268-8
10.1038/s41467-022-34268-8 · External reference
10.1016/j.tig.2021.05.002
10.1016/j.tig.2021.05.002 · External reference
10.1089/met.2015.0037
10.1089/met.2015.0037 · External reference
10.1126/scitranslmed.abf0992
10.1126/scitranslmed.abf0992 · External reference
10.1038/s41568-021-00347-z
10.1038/s41568-021-00347-z · External reference
Immunomodulation of the tumor microenvironment: turn foe into friend
10.3389/fimmu.2018.02909 · 2018 · External reference
Immunotherapy: reshape the tumor immune microenvironment
2022 · External reference
10.3389/fimmu.2020.00784
10.3389/fimmu.2020.00784 · External reference
Differentiation and regulation of TH cells: a balancing act for cancer immunotherapy
10.3389/fimmu.2021.669474 · 2021 · External reference
10.1158/0008-5472.can-14-3590
10.1158/0008-5472.can-14-3590 · External reference
10.1016/j.cellimm.2012.11.011
10.1016/j.cellimm.2012.11.011 · External reference
10.1016/j.bbamcr.2022.119321
10.1016/j.bbamcr.2022.119321 · External reference
10.1038/cdd.2014.133
10.1038/cdd.2014.133 · External reference
10.2337/db06-1448
10.2337/db06-1448 · External reference
